使SEER:

XinRong Li1, Yan Shao2, ZeMing Wang3

  • 1Department of Integrative Medicine and Medical Oncology, Shengzhou People's Hospital (the First Affiliated Hospital of Zhejiang University Shengzhou Branch), Shengzhou, Zhejiang, People's Republic of China 57258782@qq.com.

BMJ open
|December 9, 2023
PubMed
概括

这项研究开发了一个名图,以预测质瘤患者的死亡风险和治疗影响. 研究结果表明,手术,放射治疗和化疗通常会改善预后,而IDH状态会影响疗效.